Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 52 of 52 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/31/08
End: 08/31/10
Due: 08/31/11
Phase: N/A
Priority: Normal
Start: 01/31/16
End: 06/30/17
Due: 06/30/18
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer | NCT00593827 | R-Pharm | user2@example.com | None | 2008-05-31 | 2010-08-31 | 2011-08-31 | - | - | 2025-07-14 |
| Pharmacokinetics and Pharmacodynamics of RPH-104 in Healthy Subjects | NCT02667639 | R-Pharm | user2@example.com | None | 2016-01-31 | 2017-06-30 | 2018-06-30 | - | - | 2025-07-14 |